Libertyville, IL, United States of America

Jyoti R Patel

USPTO Granted Patents = 24 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 11.5

ph-index = 8

Forward Citations = 213(Granted Patents)

Company Filing History:

15 out of 4,177

Abbott Laboratories Corporation

Years Active: 2001-2016

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9464072 - Treatment of central nervous system disorders (2016-10-11),

2. 9290444 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2016-03-22),

3. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),

4. 9133145 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2015-09-15),

5. 8993632 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2015-03-31),

6. 8940902 - Treatment of central nervous system disorders (2015-01-27),

7. 8716345 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2014-05-06),

8. 8648069 - 5-substituted indazoles as kinase inhibitors (2014-02-11),

9. 8609669 - Potassium channel modulators (2013-12-17),

10. 8415354 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2013-04-09),

11. 8198331 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2012-06-12),

12. 7880001 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme (2011-02-01),

13. 7855308 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme (2010-12-21),

14. 7671076 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) (2010-03-02),

15. 7528282 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2009-05-05),

Title: Innovator Spotlight: Jyoti R Patel - Transforming Central Nervous System Treatment

Introduction:

Jyoti R Patel, a visionary inventor based in Libertyville, IL, is making significant strides in the field of healthcare with her groundbreaking patents and innovative research. With a total of 24 patents to her name, Jyoti is a trailblazer in developing treatments for central nervous system disorders.

Latest Patents:

Jyoti's recent patents focus on revolutionizing the treatment of central nervous system disorders. Her patent titled "Treatment of Central Nervous System Disorders" details a method to address a wide range of conditions such as diabetes, aging-related deficits, neurodegeneration, and mental health disorders like ADHD, Alzheimer's, depression, and schizophrenia. Another key patent involves developing inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme, offering promising solutions for diabetes, obesity, and metabolic disorders.

Career Highlights:

During her impressive career, Jyoti has contributed her expertise to renowned companies in the pharmaceutical industry. She has made significant impacts at Abbott Laboratories Corporation and AbbVie Inc., where she has spearheaded cutting-edge research projects and played a pivotal role in advancing healthcare technologies.

Collaborations:

Jyoti's collaborative spirit shines through her partnerships with esteemed colleagues in the field. Working alongside experts like Qi Shuai and James T Link, she has cultivated a dynamic environment for innovation and knowledge sharing. These collaborations have paved the way for transformative discoveries in healthcare.

Conclusion:

In conclusion, Jyoti R Patel's dedication to improving treatments for central nervous system disorders has positioned her as a leading figure in the healthcare innovation landscape. With her vast expertise, groundbreaking patents, and collaborative approach, Jyoti continues to drive progress and inspire change in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.